LTR Pharma Executes US Commercialisation Agreement with Shed DTC Platform
· smallcaps.com.au
LTR Pharma inks US ROXUS deal with Shed; targets 150k units in year one via Mavrox telehealth—fast-acting 10-min onset.
LTR Pharma (ASX: LTP) has signed a definitive telehealth distribution agreement with Shed Holdings for the planned US commercialisation of its rapid-onset intra...